Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce T Liang

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Journal of Medicinal Chemistry|January 5, 2013
5'-Phosphate and 5'-phosphonate ester derivatives of (N)-methanocarba adenosine with in vivo cardioprotective activityT Santhosh Kumar, Tiehong Yang, Shilpi Mishra, et al.
Circulation. Heart Failure|March 14, 2014
Novel protective role of endogenous cardiac myocyte P2X4 receptors in heart failureTiehong Yang, Jian-bing Shen, Ronghua Yang, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 17, 2006
P2X purinergic receptor-mediated ionic current in cardiac myocytes of calsequestrin model of cardiomyopathy: implications for the treatment of heart failureJian-Bing Shen, Chunxia Cronin, Dmitry Sonin, et al.
The American Journal of Cardiology|January 9, 2019
Usefulness of Circulating Caspase-3 p17 and Caspase-1 p20 Peptides and Cardiac Troponin 1 During Cardioplegia to Gauge Myocardial PreservationMinjung Kim, Michael K Lorinsky, Courtney A Gold, et al.
Journal of Medicinal Chemistry|September 23, 2022
Structure-Activity Relationship and Neuroprotective Activity of 1,5-Dihydro-2<i>H</i>-naphtho[1,2-<i>b</i>][1,4]diazepine-2,4(3<i>H</i>)-diones as P2X4 Receptor AntagonistsKiran S Toti, Rajkumar Verma, Michael J McGonnigle, et al.
Pharmacological Research|March 16, 2016
Reduced in vivo toxicity of doxorubicin by encapsulation in cholesterol-containing self-assembled nanoparticlesLaura Gonzalez-Fajardo, Lalit H Mahajan, Dennis Ndaya, et al.
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|July 14, 2026
MRS2339, a cardiac P2X4 receptor nucleotide activator, improves systolic function in heart failureRonghua Yang, Chunxia Cronin, Khaled Qanud, et al.
Biomaterials Science|October 30, 2023
Fluorescent liposomal nanocarriers for targeted drug delivery in ischemic stroke therapyMichael R Arul, Ibtihal Alahmadi, Daylin Gamiotea Turro, et al.
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|July 14, 2026
Novel P2X4 Receptor Antagonist MRS4719 Improves Ischemia/reperfusion Injury in MiceRajkumar Verma, Jinting Zhang, Sanjeev Kumar Yadav, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 5, 2010
Treatment of heart failure by a methanocarba derivative of adenosine monophosphate: implication for a role of cardiac purinergic P2X receptorsSi-Yuan Zhou, Mohammed Mamdani, Khaled Qanud, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Journal of Medicinal Chemistry|January 5, 2013
5'-Phosphate and 5'-phosphonate ester derivatives of (N)-methanocarba adenosine with in vivo cardioprotective activityT Santhosh Kumar, Tiehong Yang, Shilpi Mishra, et al.
Circulation. Heart Failure|March 14, 2014
Novel protective role of endogenous cardiac myocyte P2X4 receptors in heart failureTiehong Yang, Jian-bing Shen, Ronghua Yang, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 17, 2006
P2X purinergic receptor-mediated ionic current in cardiac myocytes of calsequestrin model of cardiomyopathy: implications for the treatment of heart failureJian-Bing Shen, Chunxia Cronin, Dmitry Sonin, et al.
The American Journal of Cardiology|January 9, 2019
Usefulness of Circulating Caspase-3 p17 and Caspase-1 p20 Peptides and Cardiac Troponin 1 During Cardioplegia to Gauge Myocardial PreservationMinjung Kim, Michael K Lorinsky, Courtney A Gold, et al.
Journal of Medicinal Chemistry|September 23, 2022
Structure-Activity Relationship and Neuroprotective Activity of 1,5-Dihydro-2<i>H</i>-naphtho[1,2-<i>b</i>][1,4]diazepine-2,4(3<i>H</i>)-diones as P2X4 Receptor AntagonistsKiran S Toti, Rajkumar Verma, Michael J McGonnigle, et al.
Pharmacological Research|March 16, 2016
Reduced in vivo toxicity of doxorubicin by encapsulation in cholesterol-containing self-assembled nanoparticlesLaura Gonzalez-Fajardo, Lalit H Mahajan, Dennis Ndaya, et al.
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|July 14, 2026
MRS2339, a cardiac P2X4 receptor nucleotide activator, improves systolic function in heart failureRonghua Yang, Chunxia Cronin, Khaled Qanud, et al.
Biomaterials Science|October 30, 2023
Fluorescent liposomal nanocarriers for targeted drug delivery in ischemic stroke therapyMichael R Arul, Ibtihal Alahmadi, Daylin Gamiotea Turro, et al.
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|July 14, 2026
Novel P2X4 Receptor Antagonist MRS4719 Improves Ischemia/reperfusion Injury in MiceRajkumar Verma, Jinting Zhang, Sanjeev Kumar Yadav, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 5, 2010
Treatment of heart failure by a methanocarba derivative of adenosine monophosphate: implication for a role of cardiac purinergic P2X receptorsSi-Yuan Zhou, Mohammed Mamdani, Khaled Qanud, et al.
Pageof 7